Back
Sangamo Therapeutics Stock Price Chart
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!
Sell
25
SGMO
Sangamo Therapeutics
Last Price:
$0.85
Seasonality Move:
-4.44%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGMO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sangamo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.89 | Sell |
| 20-day SMA: | 0.93 | Sell |
| 50-day SMA: | 1.06 | Sell |
| 200-day SMA: | 1.15 | Sell |
| 8-day EMA: | 0.88 | Sell |
| 20-day EMA: | 0.95 | Sell |
| 50-day EMA: | 1.13 | Sell |
| 200-day EMA: | 1.21 | Sell |
Sangamo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 38.14 | Sell |
| Chaikin Money Flow: | -1967079 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Sangamo Therapeutics Technical Analysis
| Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sangamo Therapeutics Stock
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 0.84 while SGMO 8-day simple moving average is 0.89, which is a Sell signal.
-
The stock price of SGMO is 0.84 while Sangamo Therapeutics 20-day SMA is 0.93, which makes it a Sell.
-
Sangamo Therapeutics 50-day simple moving average is 1.06 while SGMO share price is 0.84, making it a Sell technically.
-
SGMO stock price is 0.84 and Sangamo Therapeutics 200-day simple moving average is 1.15, creating a Sell signal.
SGMO Technical Analysis vs Fundamental Analysis
Sell
25
Sangamo Therapeutics (SGMO)
is a Sell
Is Sangamo Therapeutics a Buy or a Sell?
-
Sangamo Therapeutics stock is rated a SellThe current Sangamo Therapeutics [SGMO] share price is $0.84. The Score for SGMO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Sangamo Therapeutics Stock Info
Market Cap:
188.6M
Price in USD:
0.84
Share Volume:
3.7M
Sangamo Therapeutics 52-Week Range
52-Week High:
3.18
52-Week Low:
0.30
Sell
25
Sangamo Therapeutics (SGMO)
is a Sell
Sangamo Therapeutics Share Price Forecast
-
What is the Sangamo Therapeutics stock price today?The Sangamo Therapeutics stock price is 0.84 USD today.
-
Will SGMO stock go up or go down?Sangamo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sangamo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sangamo Therapeutics is overvalued.
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 0.84 while SGMO 8-day exponential moving average is 0.88, which is a Sell signal.
-
The stock price of SGMO is 0.84 while Sangamo Therapeutics 20-day EMA is 0.95, which makes it a Sell.
-
Sangamo Therapeutics 50-day exponential moving average is 1.13 while SGMO share price is 0.84, making it a Sell technically.
-
SGMO stock price is 0.84 and Sangamo Therapeutics 200-day simple moving average is 1.21, creating a Sell signal.
Fundamental Analysis of Sangamo Therapeutics
Is Sangamo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Sangamo Therapeutics
Should I short Sangamo Therapeutics stock?
-
SGMO Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Sangamo Therapeutics is a Sell
-
Sangamo Therapeutics Relative Strength Index (RSI) is 38.14, which suggest Sangamo Therapeutics is oversold
-
The Bollinger Bands (25) for Sangamo Therapeutics is ( - ), which suggest Sangamo Therapeutics is a Buy
-
The Bollinger Bands (100) for Sangamo Therapeutics is ( - ), which suggest Sangamo Therapeutics is a Buy
* Sangamo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.